Home /Research /P.2.c.013 A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in MDD treatment
OTHER

P.2.c.013 A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in MDD treatment

D. Baldwin, Henrik Loft, Marianne Dragheim

Year
2011
Citations
4

Keywords

Deep brain stimulationSubthalamic nucleusMedicinePlaceboAnesthesiaRating scaleDoseClinical endpointParkinson's diseaseLead (geology)

Related papers

Browse all OTHER papers